Endo International PLC (NASDAQ:ENDP) (TSE:ENL) Director Nancy J. Hutson sold 10,000 shares of the business’s stock in a transaction on Thursday, November 15th. The stock was sold at an average price of $12.83, for a total transaction of $128,300.00. Following the completion of the sale, the director now directly owns 49,970 shares of the company’s stock, valued at approximately $641,115.10. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.
Shares of Endo International stock traded down $0.04 during trading hours on Friday, reaching $12.69. 4,663,062 shares of the company’s stock were exchanged, compared to its average volume of 5,203,300. Endo International PLC has a 1 year low of $5.27 and a 1 year high of $18.50. The firm has a market capitalization of $2.90 billion, a price-to-earnings ratio of 3.30, a PEG ratio of 4.71 and a beta of 0.65.
Endo International (NASDAQ:ENDP) (TSE:ENL) last released its earnings results on Thursday, November 8th. The company reported $0.71 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.59 by $0.12. Endo International had a negative net margin of 37.82% and a positive return on equity of 1,348.52%. The business had revenue of $745.00 million during the quarter, compared to analyst estimates of $694.93 million. During the same quarter in the prior year, the firm earned $0.91 earnings per share. The company’s revenue for the quarter was down 5.3% compared to the same quarter last year. As a group, equities analysts expect that Endo International PLC will post 2.74 EPS for the current fiscal year.
Institutional investors have recently added to or reduced their stakes in the company. Xact Kapitalforvaltning AB grew its holdings in shares of Endo International by 44.5% during the first quarter. Xact Kapitalforvaltning AB now owns 29,215 shares of the company’s stock worth $174,000 after buying an additional 9,000 shares in the last quarter. James Investment Research Inc. grew its holdings in shares of Endo International by 594.9% during the third quarter. James Investment Research Inc. now owns 10,945 shares of the company’s stock worth $184,000 after buying an additional 9,370 shares in the last quarter. Neuberger Berman Group LLC purchased a new stake in shares of Endo International during the third quarter worth $202,000. Harvest Fund Management Co. Ltd purchased a new stake in shares of Endo International during the third quarter worth $223,000. Finally, Cim Investment Mangement Inc. purchased a new stake in shares of Endo International during the third quarter worth $262,000. 98.43% of the stock is owned by institutional investors and hedge funds.
About Endo International
Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. The company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals, and International Pharmaceuticals.
Featured Story: Swap
Receive News & Ratings for Endo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International and related companies with MarketBeat.com's FREE daily email newsletter.